InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Bonney Michael W, 董事. Director active across 2 companies, notably Bristol Myers Squibb Co. Aggregated, 8 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €4.3m. Activity tracked since 3 June 2021. The latest transaction was disclosed on 18 August 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bonney Michael W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
11,250 股@ US$70.207.6% 占其流量Common StockSEC:0001735276-25-000087:0
11,250 股@ US$450.0048.5% 占其流量Common StockSEC:0001735276-25-000087:1
11,250 股@ US$131.2114.7% 占其流量Common StockSEC:0001735276-25-000072:0
775 股0Common StockSEC:0001735276-25-000067:0
30,000 股@ US$96.4529.3% 占其流量Common StockSEC:0001735276-23-000081:0
22,477 股0Common StockSEC:0001735276-23-000071:0
902 股0Common Stock, $0.10 par valueSEC:0000014272-21-000150:0
2,949 股0Common Stock, $0.10 par valueSEC:0000014272-21-000146:0
8 条申报中的 8 条
About Bonney Michael W
Michael W. Bonney is a Board Member at Bristol Myers Squibb Co. He brings expertise in the pharmaceutical sector, contributing to the governance of the company. His role involves overseeing strategic initiatives and evaluating growth opportunities. Michael plays an important role in guiding the company's decisions regarding treatments and health solutions.
